» Articles » PMID: 3014249

Vascular Vasopressin Receptors Mediate Phosphatidylinositol Turnover and Calcium Efflux in an Established Smooth Muscle Cell Line

Overview
Journal Life Sci
Publisher Elsevier
Date 1986 Jul 7
PMID 3014249
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Vasopressin-induced phosphatidylinositol turnover and mobilization of intracellular Ca2+ was studied using an established smooth muscle cell line (A-10). The cells were subcloned to ensure a monoclonal cell population. The accumulation of inositol mono-, di-, and tris-phosphates (IP1, IP2, and IP3, respectively), and the mobilization of intracellular Ca2+ were dependent on the time of incubation and the concentration of arginine vasopressin (AVP). IP1, IP2, and IP3 were significantly elevated after 15 sec and remained elevated for up to 2 hr. The concentrations of AVP required for half-maximal stimulation of IP1, IP2, and IP3 formation were 2, 12, and 4 nM, respectively. LiCl was required to observe the accumulation of inositol phosphates in response to AVP. Significant 45Ca2+ efflux was observed within 15 sec after exposure to AVP. By employing the vasopressin receptor subtype selective antagonists [d(CH2)5Tyr(Me)AVP, V1; d(CH2)5D-Tyr(Et)VAVP,V1/V2; d(CH2) 5D-IleVAVP,V2] and agonists [AVP, V1/V2; dDAVP, V2; dVDAVP, V2], we found that the vasopressin-induced stimulation of phosphatidylinositol turnover and 45Ca2+ efflux were mediated by receptors of the vascular V1 subtype. Pertussis toxin pretreatment partially inhibited vasopressin-induced phosphatidylinositol turnover. These data demonstrate that activation of V1 receptors of vascular smooth muscle cells resulted in enhanced phosphatidylinositol turnover and mobilization of intracellular Ca2+.

Citing Articles

Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey.

Elshourbagy N, Douglas S, Shabon U, Harrison S, Duddy G, Sechler J Br J Pharmacol. 2002; 136(1):9-22.

PMID: 11976263 PMC: 1762106. DOI: 10.1038/sj.bjp.0704671.


Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment.

Avdonin P, Roulet E, Buetler T, Mermod N, Ruegg U Br J Pharmacol. 2001; 132(4):909-17.

PMID: 11181432 PMC: 1572618. DOI: 10.1038/sj.bjp.0703878.


Human AT1 receptor is a single copy gene: characterization in a stable cell line.

Aiyar N, Baker E, Wu H, Nambi P, Edwards R, Trill J Mol Cell Biochem. 1994; 131(1):75-86.

PMID: 8047068 DOI: 10.1007/BF01075727.


Inhibition of formation of cyclic AMP and cyclic GMP by vasopressin in smooth-muscle cells is insensitive to pertussis toxin.

Nambi P, Whitman M, Aiyar N, Crooke S Biochem J. 1988; 254(2):449-53.

PMID: 2845952 PMC: 1135098. DOI: 10.1042/bj2540449.


An activator of protein kinase C (phorbol dibutyrate) attenuates atrial-natriuretic-factor-stimulated cyclic GMP accumulation in smooth-muscle cells.

Nambi P, Whitman M, Aiyar N, Stassen F, Crooke S Biochem J. 1987; 244(2):481-4.

PMID: 2822009 PMC: 1148015. DOI: 10.1042/bj2440481.